CVS vs EDIT
CVS Health Corp (CVS) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CVS and EDIT stock pages for the full models.
Not investment advice.